6 results  1 of 1 

1 The Clinical Usefulness of Nuclear Matrix Protein-22 in Patients with Atypical Urine Cytology
Jae Sung Ahn, Hyun-Soo Kim, Sung-Goo Chang, Seung Hyun Jeon
Korean J Urol.2011;52(9):603-606.   Published online 2011 September 28     DOI: http://dx.doi.org/10.4111/kju.2011.52.9.603
      
2 Usefulness of the NMP22BladderChek Test for Screening and Follow-up of Bladder Cancer
Hwa Sub Choi, Sang Ik Lee, Dong Jun Kim, Tae Yoong Jeong
Korean J Urol.2010;51(2):88-93.   Published online 2010 February 18     DOI: http://dx.doi.org/10.4111/kju.2010.51.2.88
      
3 Morphological and biochemical analysis of anti-nuclear matrix protein antibodies in human sera
Eunsil Yu, Hojung Lee, Wonil Oh, Bin Yu, Heebum Moon, Inchul Lee
J Korean Med Sci.1999;14(1):27-33.   Published online 2009 June 12     DOI: http://dx.doi.org/10.3346/jkms.1999.14.1.27
      
4 Comparison of the Efficacy of Urine Cytology, Nuclear Matrix Protein 22 (NMP22), and Fluorescence in Situ Hybridization (FISH) for the Diagnosis of Bladder Cancer
Won Tae Kim, Kyeongmee Park, Nam Hoon Cho, Won Sik Ham, Jin Sun Lee, Hee Jeong Ju, Yong Uk Kwon, Young Deuk Choi
Korean J Urol.2009;50(1):6-11.   Published online 2009 January 31     DOI: http://dx.doi.org/10.4111/kju.2009.50.1.6
      
5 Evaluation of Urine NMP22 Point-of-Care Test for the Screening of Bladder Cancer
Chun Hwa Ihm, Ji Myung Kim, Yong-Hak Sohn
Korean J Lab Med.2007;27(2):106-110.   Published online 2007 February 10     DOI: http://dx.doi.org/10.3343/kjlm.2007.27.2.106
   
6 Urinary Survivin Test Compared to the Nuclear Matrix Protein (NMP)-22 Test and Urine Cytology for the Diagnosis of Bladder Cancer
Sang Hoon Chang, Young Ho Kim, Min Eui Kim
Korean J Urol.2006;47(10):1041-1045.   Published online 2006 October 31     DOI: http://dx.doi.org/10.4111/kju.2006.47.10.1041
      

 1 of 1